Feedback / Questions
quilizumab (MEMP1972A) - Roche
Roche: HY 2014 Results
(Roche)
-
Jul 25, 2014 -
Anticipated NME submission in US for asthma in 2017 or later; Anticipated NME submission in EU for asthma in 2017 or later
Anticipated BLA • Anticipated EU regulatory
•
Asthma
http://www.roche.com/investors/ir_agenda/halfyear-2014.htm
Jul 25, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.